Published by Iain Gilbert on 14th August 2020
(Sharecast News) - Liquid biopsy company Angle said on Friday that breakthrough research had shown the potential use of Parsortix to assess whether or not patients would respond to immunotherapy.
URL: http://www.digitallook.com/dl/news/story/31058206/...